+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Disease Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 180 Pages
  • April 2023
  • Region: Global
  • Infinium Global Research
  • ID: 5789674
Description Jump to:
The report on the global respiratory disease vaccine market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global respiratory disease vaccine market to grow with a CAGR of above 5% over the forecast period from 2023-2030. The study on respiratory disease vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on respiratory disease vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global respiratory disease vaccine market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global respiratory disease vaccine market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The prevalence of respiratory diseases such as asthma, tuberculosis, pneumonia, and lung cancer is driving the growth of the market.
  • Growing healthcare expenditure is also supporting the growth of the market.

2) Restraints

  • Strict policies by the government for the approval of vaccines may hamper the growth of the market.

3) Opportunities

  • The growing findings will provide a growth opportunity to expand the respiratory disease vaccine market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global respiratory disease vaccine market is segmented on the basis of disease type, and vaccine.

The Global Respiratory Disease Vaccine Market by Disease Type

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pertussis
  • Pneumonia
  • Measles
  • Diphtheria

The Global Respiratory Disease Vaccine Market by Vaccine

  • DTaP
  • PPSV23
  • MMR
  • Haemophilus Influenzae Type B (HIB)
  • Respiratory Syncytial Virus (RSV)

Company Profiles

The companies covered in the report include
  • Sanofi
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bavarian Nordic
  • EMERGENT
  • CSL Limited
  • Moderna, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the respiratory disease vaccine market.
2. Complete coverage of all the segments in the respiratory disease vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global respiratory disease vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Respiratory Disease Vaccine Market Highlights
2.2. Respiratory Disease Vaccine Market Projection
2.3. Respiratory Disease Vaccine Market Regional Highlights
Chapter 3. Global Respiratory Disease Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Disease Type
3.4.2. Growth Matrix Analysis by Vaccine
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Respiratory Disease Vaccine Market
3.6. TAM SAM SOM Analysis for Respiratory Disease Vaccine Market
3.6.1. TAM SAM SOM Forecast Analysis (USD Billion) 2023
Chapter 4. Respiratory Disease Vaccine Market Macro Indicator Analysis
Chapter 5. Global Respiratory Disease Vaccine Market by Disease Type
5.1. Chronic Obstructive Pulmonary Disease (COPD)
5.2. Pertussis
5.3. Pneumonia
5.4. Measles
5.5. Diphtheria
Chapter 6. Global Respiratory Disease Vaccine Market by Vaccine
6.1. DTaP
6.2. PPSV23
6.3. MMR
6.4. Haemophilus Influenzae Type B (HIB)
6.5. Respiratory Syncytial Virus (RSV)
Chapter 7. Global Respiratory Disease Vaccine Market by Region 2023-2030
7.1. North America
7.1.1. North America Respiratory Disease Vaccine Market by Disease Type
7.1.2. North America Respiratory Disease Vaccine Market by Vaccine
7.1.3. North America Respiratory Disease Vaccine Market by Country
7.1.3.1. The U.S. Respiratory Disease Vaccine Market
7.1.3.1.1. The U.S. Respiratory Disease Vaccine Market by Disease Type
7.1.3.1.2. The U.S. Respiratory Disease Vaccine Market by Vaccine
7.1.3.2. Canada Respiratory Disease Vaccine Market
7.1.3.2.1. Canada Respiratory Disease Vaccine Market by Disease Type
7.1.3.2.2. Canada Respiratory Disease Vaccine Market by Vaccine
7.1.3.3. Mexico Respiratory Disease Vaccine Market
7.1.3.3.1. Mexico Respiratory Disease Vaccine Market by Disease Type
7.1.3.3.2. Mexico Respiratory Disease Vaccine Market by Vaccine
7.2. Europe
7.2.1. Europe Respiratory Disease Vaccine Market by Disease Type
7.2.2. Europe Respiratory Disease Vaccine Market by Vaccine
7.2.3. Europe Respiratory Disease Vaccine Market by Country
7.2.3.1. Germany Respiratory Disease Vaccine Market
7.2.3.1.1. Germany Respiratory Disease Vaccine Market by Disease Type
7.2.3.1.2. Germany Respiratory Disease Vaccine Market by Vaccine
7.2.3.2. United Kingdom Respiratory Disease Vaccine Market
7.2.3.2.1. United Kingdom Respiratory Disease Vaccine Market by Disease Type
7.2.3.2.2. United Kingdom Respiratory Disease Vaccine Market by Vaccine
7.2.3.3. France Respiratory Disease Vaccine Market
7.2.3.3.1. France Respiratory Disease Vaccine Market by Disease Type
7.2.3.3.2. France Respiratory Disease Vaccine Market by Vaccine
7.2.3.4. Italy Respiratory Disease Vaccine Market
7.2.3.4.1. Italy Respiratory Disease Vaccine Market by Disease Type
7.2.3.4.2. Italy Respiratory Disease Vaccine Market by Vaccine
7.2.3.5. Spain Respiratory Disease Vaccine Market
7.2.3.5.1. Spain Respiratory Disease Vaccine Market by Disease Type
7.2.3.5.2. Spain Respiratory Disease Vaccine Market by Vaccine
7.2.3.6. Rest of Europe Respiratory Disease Vaccine Market
7.2.3.6.1. Rest of Europe Respiratory Disease Vaccine Market by Disease Type
7.2.3.6.2. Rest of Europe Respiratory Disease Vaccine Market by Vaccine
7.3. Asia Pacific
7.3.1. Asia Pacific Respiratory Disease Vaccine Market by Disease Type
7.3.2. Asia Pacific Respiratory Disease Vaccine Market by Vaccine
7.3.3. Asia Pacific Respiratory Disease Vaccine Market by Country
7.3.3.1. China Respiratory Disease Vaccine Market
7.3.3.1.1. China Respiratory Disease Vaccine Market by Disease Type
7.3.3.1.2. China Respiratory Disease Vaccine Market by Vaccine
7.3.3.2. Japan Respiratory Disease Vaccine Market
7.3.3.2.1. Japan Respiratory Disease Vaccine Market by Disease Type
7.3.3.2.2. Japan Respiratory Disease Vaccine Market by Vaccine
7.3.3.3. India Respiratory Disease Vaccine Market
7.3.3.3.1. India Respiratory Disease Vaccine Market by Disease Type
7.3.3.3.2. India Respiratory Disease Vaccine Market by Vaccine
7.3.3.4. South Korea Respiratory Disease Vaccine Market
7.3.3.4.1. South Korea Respiratory Disease Vaccine Market by Disease Type
7.3.3.4.2. South Korea Respiratory Disease Vaccine Market by Vaccine
7.3.3.5. Rest of Asia-Pacific Respiratory Disease Vaccine Market
7.3.3.5.1. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Disease Type
7.3.3.5.2. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Vaccine
7.4. RoW
7.4.1. RoW Respiratory Disease Vaccine Market by Disease Type
7.4.2. RoW Respiratory Disease Vaccine Market by Vaccine
7.4.3. RoW Respiratory Disease Vaccine Market by Sub-region
7.4.3.1. Latin America Respiratory Disease Vaccine Market
7.4.3.1.1. Latin America Respiratory Disease Vaccine Market by Disease Type
7.4.3.1.2. Latin America Respiratory Disease Vaccine Market by Vaccine
7.4.3.2. Middle East Respiratory Disease Vaccine Market
7.4.3.2.1. Middle East Respiratory Disease Vaccine Market by Disease Type
7.4.3.2.2. Middle East Respiratory Disease Vaccine Market by Vaccine
7.4.3.3. Africa Respiratory Disease Vaccine Market
7.4.3.3.1. Africa Respiratory Disease Vaccine Market by Disease Type
7.4.3.3.2. Africa Respiratory Disease Vaccine Market by Vaccine
Chapter 8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Respiratory Disease Vaccine Market
8.2. Companies Profiles
8.2.1. Sanofi
8.2.2. GSK plc
8.2.3. Merck & Co., Inc.
8.2.4. Pfizer Inc.
8.2.5. Bavarian Nordic
8.2.6. EMERGENT
8.2.7. CSL Limited
8.2.8. Moderna, Inc.
8.2.9. Serum Institute of India Pvt. Ltd.
8.2.10. Sinovac Biotech

Companies Mentioned

  • Sanofi
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bavarian Nordic
  • EMERGENT
  • CSL Limited
  • Moderna, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech

Related Topics

Related Reports

Respiratory Disease Vaccine Global Market Report 2024 - Product Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Respiratory Disease Vaccine Market by Infection, Type, Age Group - Global Forecast 2025-2030 - Product Image

Respiratory Disease Vaccine Market by Infection, Type, Age Group - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032 - Product Image

Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032

  • Report
  • 200 Pages
  • Global
From
RNA-based Therapeutics and Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

RNA-based Therapeutics and Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 177 Pages
  • Global
U.S. Respiratory Syncytial Virus Vaccines Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.) - Product Image

U.S. Respiratory Syncytial Virus Vaccines Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.)

  • Report
  • 304 Pages
  • United States
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.